Clinical Topics

Colonoscopy Linked to Lower CRC Mortality in Veterans

by U.S. Medicine

June 15, 2018

INDIANAPOLIS, IN — Colonoscopy is heavily promoted in the VA healthcare system, and a new study sought to document its effect on colorectal cancer (CRC) mortality rates.

The goals of the research published in Annals of Internal MedicineM. were both to determine whether colonoscopy is associated with decreased CRC mortality in veterans and to find out whether its effect differs by anatomical location of CRC.1

The case-control study was conducted by a team led by researchers from the Richard L. Roudebush VAMC and Indiana University School of Medicine, both in Indianapolis. VA-Medicare administrative data was used in the investigation.

Participants were veterans 52 or older who were diagnosed with CRC between 2002 and 2008 and died of the disease by the end of 2010. Those nearly 5,000 patients were each matched to four control patients without prior CRC on the basis of age, sex and facility.

For the study, exposure to colonoscopy was determined from 1997 to six months before CRC diagnosis in case patients and to a corresponding date in control patients. Patients who had undergone screening colonoscopy were included in a subgroup analysis.

Results indicated that “case” patients—those who had died of CRC—were significantly less likely to have undergone any colonoscopy (OR, 0.39 [95% CI, 0.35 to 0.43]). Researchers determined that colonoscopy was associated with reduced mortality for left-sided cancer (OR, 0.28 [CI, 0.24 to 0.32]) and right-sided cancer (OR, 0.54 [CI, 0.47 to 0.63]).

The study team noted that results were similar for patients who had undergone screening colonoscopy (overall OR, 0.30 [CI, 0.24 to 0.38]).

“In this study using national VA-Medicare data, colonoscopy was associated with significant reductions in CRC mortality among veterans and was associated with greater benefit for left-sided cancer than right-sided cancer,” the study authors concluded.

1Kahi CJ, Pohl H, Myers LJ, Mobarek D, Robertson DJ, Imperiale TF. Colonoscopy and Colorectal Cancer Mortality in the Veterans Affairs Health Care System: A Case-Control Study. Ann Intern Med. 2018 Apr 3;168(7):481-488. doi: 10.7326/M17-0723. Epub 2018 Mar 6. PubMed PMID: 29532085.

Comments are closed here.

Related Articles

VA Overall Appointment Wait Times Shorter than the Private-Sector

Despite intense scrutiny of wait times for veterans seeking VA care over the last three years, a new study pointed out that delays in the private sector weren’t statistically less in 2014 and that, possibly because of the focus, wait times now are significantly shorter for the VA compared to private-sector healthcare facilities.

Senate Blocks Agent Orange Exposure Extension to Blue Water Veterans

Blue Water Navy veterans who claim to be impacted by toxic exposure while serving off the coast of Vietnam were forced to grapple with disappointment once again as the 115th Congress ended without passing legislation addressing their VA benefits.

U.S. Medicine Recommends

More From oncology


Hypertension, MGUS Associated with Herbicide Exposure in Vietnam Veterans

Based on a new review, two conditions–one extremely common and the other rare–appear to be related to herbicide exposure during the Vietnam War era.


Detailed Medical History Crucial for Lung Disease Diagnosis

Both general medicine physicians and specialists can find interstitial lung disease (ILD) and pulmonary fibrosis confusing, according to a recent study.


Melanomas Associated With Internal Malignancy Risk

Genetic and environmental risk factors have been associated with the development of multiple primary melanomas (MPM) but a new study questioned whether those patients might have increased predisposition to developing internal malignancies.


Some RCC Risk Factors Can Be Modified

Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study.


Better Survival for NSCLC Patients Treated by Military Medicine

Does universal healthcare access provided by the MHS translate into improved patient outcomes for non-small cell lung cancer?